antiCG Cancer Research Results

antiCG, anticoagulant: Click to Expand ⟱
Source:
Type:

anticoagulant: anticoagulants slow down the body's chemical clotting process by targeting blood proteins



Scientific Papers found: Click to Expand⟱
8695- CAP,    Advances in cold atmospheric plasma therapy for cancer
- Review, Var, NA
Apoptosis↑, Pyro↑, Ferroptosis↑, necrosis↑, Bacteria↓, antiCG↓, ChemoSen↑, ROS↑, RNS↑, cl‑Casp3↑, BAX↑, PARP↑, Casp8↑, P53↑, Akt↓, Bcl-2↓, GSH↓, MDA↑, Iron↑, MAPK↓, MMP9↓, TumCG↓, selectivity↑, toxicity↝,
7025- Fuc,    Pilot clinical study to evaluate the anticoagulant activity of fucoidan
- Human, Nor, NA
*Dose↝, *BioAv↓, *antiCG↝,
7565- HYP,    Potential Implications of Hyperoside on Oxidative Stress-Induced Human Diseases: A Comprehensive Review
- Review, AD, NA
*Inflam↓, *antiOx↑, *neuroP↑, *lipid-P↓, *ROS↓, *IL1β↓, *IL6↓, *IL8↓, *TNF-α↓, *MDA↓, *BAX↓, *Casp3↓, *Catalase↑, *SOD↑, *GSH↑, *BDNF↑, *TrkB↑, *NGF↑, *BDNF↑, *NF-kB↓, *AChE↓, *H2S↑, Casp3↑, Apoptosis↑, NF-kB↓, AMPK↑, HO-1↑, MAPK↑, cl‑Casp3↑, cl‑Casp9↑, BAX↑, SOD?, Catalase↓, NRF2↓, NQO1↓, HO-1↓, Bcl-2↓, TumCCA↑, FOXO1↑, TumAuto↑, Akt↓, mTOR↓, P70S6K↓, BMP7/OP1↓, *cardioP↑, *hepatoP↑, *antiCG↑, *AntiThr↑, *Diar↓, *AntiFungal↑, *CYP2D6↓, *PDGFR-BB↓, *PDGFRB↓, *toxicity↓, *Half-Life↑,
9254- ISO, IH,    Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
- Review, Var, NA
MMP2↓, MMP9↓, MAPK↓, STAT3↓, Akt↓, mTOR↓, MEK↓, ERK↓, TumCP↓, TumCM/A↓, LDH↓, EMT↓, Casp3↑, Cyt‑c↑, BAX↑, cl‑Casp3↑, cl‑PARP↑, TumCCA?, AMPK↑, ROS↑, COX2/PTGS2↓, *cardioP↑, *hepatoP↑, *neuroP↑, *RenoP↑, *AntiViral↑, *antiCG↑, *AntiAg↑, *AntiThr↑,
8960- mushLions,    Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway
- Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *NGF↑, *other↝, *antiOx↑, *Inflam↓, *antiCG↑, *Bacteria↓, *hyperG↝, *AntiDiabetic↑, *AntiCan↑, *neuroG↑, *cognitive↑, *Stroke↓, *IL1β↓, *IL6↓, *TNF-α↓, *RNS↓, *iNOS↓, *MAPK↓, *CHOP/DDIT3↓, TumCD↓, ROS↑, TumCP↓, TumCI↓, ROCK1↓, LIMK2↓, Cofilin↓, PI3K↓, mTOR↓, P70S6K↓, TumCMig↓, TumMeta↓, TGF-β↓, MMP9↓, *AntiAge↑, *RIP1↓, *cl‑Casp8↓, *cl‑Casp3↓, *NRF2↑, *HO-1↑, *SOD1↑,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

Catalase↓, 1,   GSH↓, 1,   HO-1↓, 1,   HO-1↑, 1,   Iron↑, 1,   MDA↑, 1,   NQO1↓, 1,   NRF2↓, 1,   RNS↑, 1,   ROS↑, 3,   SOD?, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

AMPK↑, 2,   TumCM/A↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 2,   BAX↑, 3,   Bcl-2↓, 2,   Casp3↑, 2,   cl‑Casp3↑, 3,   Casp8↑, 1,   cl‑Casp9↑, 1,   Cyt‑c↑, 1,   Ferroptosis↑, 1,   necrosis↑, 1,   Pyro↑, 1,   TumCD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   ERK↓, 1,   MAPK↓, 2,   MAPK↑, 1,   MEK↓, 1,   mTOR↓, 3,   P70S6K↓, 2,   PI3K↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

FOXO1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

P53↑, 1,   PARP↑, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TumCCA?, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP7/OP1↓, 1,   TumCG↓, 1,   TumCP↓, 2,  

Migration(tgid=13) ⓘ

Cofilin↓, 1,   EMT↓, 1,   LIMK2↓, 1,   MMP2↓, 1,   MMP9↓, 3,   ROCK1↓, 1,   TGF-β↓, 1,   TumCI↓, 1,   TumCMig↓, 1,   TumMeta↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 1,   NF-kB↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ChemoSen↑, 1,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

LDH↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiCG↓, 1,   toxicity↝, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,  
Total Targets: 62

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Catalase↑, 1,   GSH↑, 1,   HO-1↑, 1,   hyperG↝, 1,   lipid-P↓, 1,   MDA↓, 1,   NRF2↑, 1,   RNS↓, 1,   ROS↓, 1,   SOD↑, 1,   SOD1↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

H2S↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   cl‑Casp3↓, 1,   cl‑Casp8↓, 1,   iNOS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

MAPK↓, 1,   PDGFR-BB↓, 1,   PDGFRB↓, 1,   RIP1↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   other↝, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

neuroG↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL1β↓, 2,   IL6↓, 2,   IL8↓, 1,   Inflam↓, 2,   NF-kB↓, 1,   TNF-α↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,   BDNF↑, 2,   NGF↑, 2,   TrkB↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   CYP2D6↓, 1,   Dose↝, 1,   Half-Life↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

IL6↓, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↑, 1,   antiCG↑, 3,   antiCG↝, 1,   AntiDiabetic↑, 1,   cardioP↑, 2,   cognitive↑, 1,   hepatoP↑, 2,   neuroP↑, 3,   RenoP↑, 1,   Stroke↓, 1,   toxicity↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1,   AntiViral↑, 1,   Bacteria↓, 1,   Diar↓, 1,  
Total Targets: 58

Scientific Paper Hit Count for: antiCG, anticoagulant
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Fucoidan
1 Hyperoside
1 Isorhamnetin
1 Mushroom Lion’s Mane, Hericium erinaceus
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1566  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page